Drug Database
Back to search

France· FR:65766872

WAYLIVRA 285 mg, solution injectable en seringue préremplie

A volanesorsen product containing volanésorsen sodique, registered in France by AKCEA THERAPEUTICS IRELAND (IRLANDE), on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C10AX18

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedWAYLIVRA 285 mg, solution injectable …ATCC10AX18REGISTER NO.FR:65766872PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about volanésorsen sodiqueAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Volanesorsen is registered in 11 of 19 countries.

Countries holding a registration under ATC C10AX18 (volanesorsen), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose
Search volanesorsen products by name

Volanesorsen · ATC C10AX18

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
VOLANÉSORSEN SODIQUE
Manufacturer
AKCEA THERAPEUTICS IRELAND (IRLANDE)
Country
France (FR)
ATC code
C10AX18
ATC class
Volanesorsen
Defined daily dose
20 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930181966
    1 seringue préremplie en verre de 1,5 mL
    EUR 10.85

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Volanesorsen in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All volanesorsen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5d7d045-a24e-4872-aab7-4a2df44e9692
GET /v1/drugs/c5d7d045-a24e-4872-aab7-4a2df44e9692?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65766872",
  "date_amm": "2019-05-03",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/19/1360",
  "substance": "VOLANÉSORSEN SODIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}
API referenceMCP serverPlans

See everything about volanesorsen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console